Weekly Recap | Accenture -1.42%, Anthropic AI evaluation tie-up
I'm LongbridgeAI, I can summarize articles.Accenture (ACN) fell 1.42% this week to close at $181.29, underperforming the S&P 500, which slipped 0.08%, by about 1.34 percentage points. The stock opened Monday at $190.55, hit a weekly high of $197.63 on Tuesday, then slid through the rest of the week, touching $180.70 on Friday before settling at $181.29. Weekly amplitude was 8.88%. Friday’s volume of 11.7 million shares was well above the prior four days’ range of roughly 3 to 5.
The Week
Accenture (ACN) fell 1.42% this week to close at $181.29, underperforming the S&P 500, which slipped 0.08%, by about 1.34 percentage points. The stock opened Monday at $190.55, hit a weekly high of $197.63 on Tuesday, then slid through the rest of the week, touching $180.70 on Friday before settling at $181.29. Weekly amplitude was 8.88%. Friday’s volume of 11.7 million shares was well above the prior four days’ range of roughly 3 to 5.8 million, making it the heaviest session of the week.
Key Events
The week’s main thread ran through AI safety partnerships and a regulatory settlement. On Monday, Accenture rose 3.75% in pre-market trading after Goldman Sachs reiterated its buy rating and Morgan Stanley raised its price target, pushing the stock up more than 5% intraday. On Tuesday, the company agreed to pay $25 million to settle US government allegations over DEI practices, drawing attention to compliance costs. After Friday’s close, Accenture and Anthropic announced a partnership to build a team of embedded evaluators at Anthropic, with the two companies investing $2 billion in AI model evaluation; Anthropic selected Accenture as its first embedded evaluator. Meanwhile, Guggenheim downgraded the stock ahead of the fourth-quarter print, arguing the rally had gone too far, and ACN fell 3.50% on Friday, extending losses after hours.
Analyst Ratings
As of this week, 30 institutions cover Accenture: 10 rate it buy, 3 overweight, 14 hold, and 3 no opinion, with no sell or underweight ratings. The consensus rating is buy, and the consensus target price is $186.95, about 3.12% above the closing price of $181.29. Target prices range from $130 to $275, reflecting a wide spread. Accenture ranks second among 35 companies in the IT consulting industry for analyst ratings.
The Week Ahead
The key catalyst ahead is Accenture’s fourth-quarter and full-year fiscal 2026 earnings release on 30 September, due before market open, with estimates at $3.177 EPS and $18 billion revenue. On the macro side, US initial jobless claims, the current account balance, and new home sales land on 24 September, while the Richmond Fed composite index arrives on 22 September. Watch also for any follow-up on the Anthropic AI evaluation partnership and further rating moves into the print.
In Short
Accenture moved on two fronts this week — expanding its AI safety footprint with Anthropic while settling a DEI-related claim with the US government — but the stock faded after an early spike and sold off on heavier volume Friday. Ratings show a split: the consensus is still buy with a target above spot, yet Guggenheim cut its rating before earnings, and the $130–$275 target range signals wide disagreement. Valuation sits at roughly 15.4x P/E with a 3.60% dividend yield. The next test is whether the 30 September earnings report confirms the pace of AI-related revenue, and which way money flows after Friday’s high-volume decline.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
